Targeting HDAC6 to reduce the aggressiveness of metastatic breast cancer in immunotherapy

被引：1
|
作者：
Banik, Debarati [1 ]
Hadley, Melissa [1 ]
Palmer, Erica [1 ]
Gallub, Vincent [1 ]
Sotomayor, Eduardo [1 ]
Kozikowski, Alan [2 ]
Villagra, Alejandro [1 ]
机构：
[1] George Washington Univ, Hyattsville, MD USA
[2] Starwise, Madison, WI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-48
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
    Zhou, Bingyi
    Liu, Deliang
    Tan, Yuyong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] Dido3-dependent HDAC6 targeting controls cilium size
    Sanchez de Diego, Ainhoa
    Alonso Guerrero, Astrid
    Martinez-A, Carlos
    van Wely, Karel H. M.
    NATURE COMMUNICATIONS, 2014, 5
  • [43] Mitochondrial NIR imaging probe mitigating oxidative damage by targeting HDAC6
    Kim, Jungryun
    Jangili, Paramesh
    Kim, Jeongah
    Lucia, Stephani Edwina
    Ryu, Jae Ryun
    Prasad, Renuka
    Zi, Soyu
    Kim, Pilhan
    Sun, Woong
    Kim, Jong Seung
    CHEMICAL COMMUNICATIONS, 2023, 59 (67) : 10109 - 10112
  • [44] HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
    Passaro, Eugenia
    Papulino, Chiara
    Chianese, Ugo
    Toraldo, Antonella
    Congi, Raffaella
    Del Gaudio, Nunzio
    Nicoletti, Maria Maddalena
    Benedetti, Rosaria
    Altucci, Lucia
    CANCERS, 2021, 13 (24)
  • [45] Dido3-dependent HDAC6 targeting controls cilium size
    Ainhoa Sánchez de Diego
    Astrid Alonso Guerrero
    Carlos Martínez-A
    Karel H. M. van Wely
    Nature Communications, 5
  • [46] HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer
    Banik, Debarati
    Noonepalle, Satish
    Hadley, Melissa
    Palmer, Erica
    Gracia-Hernandez, Maria
    Zevallos-Delgado, Christian
    Manhas, Namratta
    Simonyan, Hayk
    Young, Colin N.
    Popratiloff, Anastas
    Chiappinelli, Katherine B.
    Fernandes, Rohan
    Sotomayor, Eduardo M.
    Villagra, Alejandro
    CANCER RESEARCH, 2020, 80 (17) : 3649 - 3662
  • [47] Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design
    Peng, Jie
    Xie, Fei
    Qin, Pengxia
    Liu, Yujing
    Niu, Haoqian
    Sun, Jie
    Xue, Haoyu
    Zhao, Qianlong
    Liu, Jingqian
    Wu, Jingde
    BIOORGANIC CHEMISTRY, 2023, 138
  • [48] Overcome the tumor immunotherapy resistance by combination of the HDAC6 inhibitors with antitumor immunomodulatory agents
    Khamis, Mussa Yussuf
    Wu, Hui-Pan
    Ma, Qin
    Li, Yi-Han
    Ma, Li-Ying
    Zhang, Xin-Hui
    Liu, Hong-Min
    BIOORGANIC CHEMISTRY, 2021, 109
  • [49] HDAC6 inhibition disrupts HDAC6-P300 interaction reshaping the cancer chromatin landscape
    Zamperla, Michela Gottardi
    Illi, Barbara
    Barbi, Veronica
    Cencioni, Chiara
    Santoni, Daniele
    Gagliardi, Stella
    Garofalo, Maria
    Zingale, Gabriele Antonio
    Pandino, Irene
    Sbardella, Diego
    Cipolla, Lina
    Sabbioneda, Simone
    Farsetti, Antonella
    Ripamonti, Chiara
    Fossati, Gianluca
    Steinkuhler, Christian
    Gaetano, Carlo
    Atlante, Sandra
    CLINICAL EPIGENETICS, 2024, 16 (01)
  • [50] HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia
    Lize, Muriel
    Horstmann, Sigrid
    Dusterhus, Vera
    Wiedwald, Cornelia
    Ebert, Carolin
    Addante, Annalisa
    Neideck, Carlos
    Frank, Stefan
    Sohler, Florian
    Koch, Markus
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345